ACY-1083 is primarily used in research settings to study its potential therapeutic effects, particularly in the field of neurodegenerative diseases. It functions as a selective inhibitor of histone deacetylase 6 (HDAC6), an enzyme involved in various cellular processes. By inhibiting HDAC6, ACY-1083 helps in reducing the accumulation of misfolded proteins, which is a common issue in conditions like Alzheimer's disease. Researchers are exploring its ability to enhance cognitive functions and mitigate neuroinflammation. Additionally, it is being investigated for its role in cancer therapy, where it may help in inducing cell death in certain types of cancer cells. Its application is still in the experimental phase, with ongoing studies to determine its efficacy and safety in clinical settings.